Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Hyam I. Levitsky"'
Autor:
Shawn W. Robinson, Peter W. Cho, Hyam I. Levitsky, Jean L. Olson, Ralph H. Hruban, Michael A. Acker, Paul D. Kessler
Publikováno v:
Cell Transplantation, Vol 5 (1996)
The ability to replace damaged myocardial tissue with new striated muscle would constitute a major advance in the treatment of diseases that irreversibly injure cardiac muscle cells. The creation of focal grafts of skeletal muscle has been reported f
Externí odkaz:
https://doaj.org/article/06a73e78bc12401d828105b588e5bbf8
Autor:
Hyam I. Levitsky, Kristen Hege, Richard Jones, Guang Haun Tu, Thomas C. Harding, Barbara Biedrzycki, Christina Chia, Lu Qin, Hua-Ling Tsai, Elizabeth Garrett-Mayer, Carole B. Miller, Kathleen Murphy, Christopher Gocke, Jeanne Kowalski, Yvette L. Kasamon, B. Douglas Smith
Purpose: Chronic myeloid leukemia (CML) can be responsive to T-cell–mediated immunity. K562/granulocyte macrophage-colony stimulating factor (GM-CSF) is a GM-CSF producing vaccine derived from a CML cell line that expresses several CML-associated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259cce9075d95e9c8508b5e08dc816d5
https://doi.org/10.1158/1078-0432.c.6518467
https://doi.org/10.1158/1078-0432.c.6518467
Autor:
Hyam I. Levitsky, Kristen Hege, Richard Jones, Guang Haun Tu, Thomas C. Harding, Barbara Biedrzycki, Christina Chia, Lu Qin, Hua-Ling Tsai, Elizabeth Garrett-Mayer, Carole B. Miller, Kathleen Murphy, Christopher Gocke, Jeanne Kowalski, Yvette L. Kasamon, B. Douglas Smith
Supplementary Data from K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ae04ff2945ed73b9f14b49f95b4e63
https://doi.org/10.1158/1078-0432.22441387.v1
https://doi.org/10.1158/1078-0432.22441387.v1
Supplementary Figure 2 from Magnetovaccination as a Novel Method to Assess and Quantify Dendritic Cell Tumor Antigen Capture and Delivery to Lymph Nodes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7451d4e7039345ee4af824ad9f6111
https://doi.org/10.1158/0008-5472.22381439
https://doi.org/10.1158/0008-5472.22381439
Supplementary Figure 1 from Magnetovaccination as a Novel Method to Assess and Quantify Dendritic Cell Tumor Antigen Capture and Delivery to Lymph Nodes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a278b798eb252e226539561dca96c91
https://doi.org/10.1158/0008-5472.22381442.v1
https://doi.org/10.1158/0008-5472.22381442.v1
Supplementary Figure Legends 1-2, Video Legend from Magnetovaccination as a Novel Method to Assess and Quantify Dendritic Cell Tumor Antigen Capture and Delivery to Lymph Nodes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acd374fcf4425e84545c05be4c93110c
https://doi.org/10.1158/0008-5472.22381436.v1
https://doi.org/10.1158/0008-5472.22381436.v1
A major parameter limiting immune responses to vaccination is the number of activated antigen-presenting cells (APC) that capture antigen and migrate to draining lymph nodes (LN). Currently, a quantitative noninvasive technique for monitoring in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3ed2e25e73b2d08afd3168986e4273
https://doi.org/10.1158/0008-5472.c.6499868.v1
https://doi.org/10.1158/0008-5472.c.6499868.v1
Supplementary Video 1 from Magnetovaccination as a Novel Method to Assess and Quantify Dendritic Cell Tumor Antigen Capture and Delivery to Lymph Nodes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c810a5e3100dee84ac076d4cd455ec1
https://doi.org/10.1158/0008-5472.22381433.v1
https://doi.org/10.1158/0008-5472.22381433.v1
Autor:
Polina Sysa-Shah, Jon Jones, Steven P. Rowe, Yong Du, Andrew Park, Mary Brummet, Tamara M. Chinn, David Jeffrey Huss, Hye Hyun Ahn, Il Minn, Martin G. Pomper, Hyam I. Levitsky
Publikováno v:
Radiol Imaging Cancer
Chimeric antigen receptor (CAR) T cell therapy for hematologic malignancies is fraught with several unknowns, including number of functional T cells that engage target tumor, durability and subsequent expansion and contraction of that engagement, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e6cbf59ddbb01820468dfdbf50bbb83
https://pubmed.ncbi.nlm.nih.gov/33778677
https://pubmed.ncbi.nlm.nih.gov/33778677
Autor:
Hyam I. Levitsky, Madan Jagasia, Natasha A. Jain, Nancy F. Hensel, Christopher S. Hourigan, T Rajkhowa, Hossein Sadrzadeh, Sawa Ito, James W. Fraser, Meghali Goswami, Minoo Battiwalla, Amir T. Fathi, Austin John Barrett, Stephen A. Strickland, Lu Qin, Gabrielle T. Prince, Mark J. Levis, B D Smith, Bipin N. Savani
Publikováno v:
Leukemia
Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e2f35143ae68ab47254057e5886bbb
https://doi.org/10.1038/leu.2014.14
https://doi.org/10.1038/leu.2014.14